- Report
- January 2024
- 253 Pages
Global
From €5288EUR$5,500USD£4,537GBP
- Report
- March 2024
- 188 Pages
Global
From €3244EUR$3,374USD£2,783GBP
€3605EUR$3,749USD£3,092GBP
- Report
- February 2024
- 173 Pages
Global
From €5721EUR$5,950USD£4,908GBP
- Report
- February 2024
- 250 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- February 2024
- 400 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- February 2024
- 175 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- February 2024
- 175 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- February 2024
- 200 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- January 2024
- 200 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- January 2024
- 200 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- June 2023
- 180 Pages
Global
From €3606EUR$3,750USD£3,093GBP
- Report
- May 2023
- 156 Pages
Global
From €3063EUR$3,185USD£2,627GBP
€4375EUR$4,550USD£3,753GBP
- Report
- February 2024
- 180 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- November 2023
- 182 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- November 2023
- 178 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- November 2022
- 550 Pages
Global
From €4614EUR$4,799USD£3,959GBP
- Report
- January 2022
- 209 Pages
Global
From €4614EUR$4,799USD£3,959GBP
- Report
- January 2022
- 175 Pages
Global
From €4614EUR$4,799USD£3,959GBP
- Report
- June 2020
- 100 Pages
China
From €2356EUR$2,450USD£2,021GBP
- Report
- November 2022
- 705 Pages
Global
From €6923EUR$7,200USD£5,939GBP
Biologics Development is a field of drug discovery that focuses on the development of biopharmaceuticals, which are drugs derived from living organisms. This includes proteins, peptides, nucleic acids, and other molecules. The process of biologics development involves the identification of a target molecule, the design of a drug to interact with the target, and the production of the drug. The development of biologics requires a deep understanding of the biology of the target molecule, as well as the ability to produce the drug in a cost-effective manner.
Biologics Development is a rapidly growing field, with many companies investing in the development of new biopharmaceuticals. Companies such as Amgen, Biogen, Genentech, and Novartis are leading the way in the development of biologics. Other companies such as AbbVie, AstraZeneca, and Merck are also investing in the development of biologics. These companies are working to develop new treatments for a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. Show Less Read more